The Drug Enforcement Administration (DEA) in concert with the Department of Health and Human Services (HHS) is issuing a third extension of telemedicine flexibilities for the prescribing of controlled medications, through December 31, 2025.
US Federal Register - DEA Telehealth Rules · November 19, 2024
Third Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications
DEA extends telemedicine flexibilities for controlled-medication prescribing through December 31, 2025.
Applies from
2025-01-01
Published by US Federal Register - DEA Telehealth Rules. HealthSignal links to the original document; the summary above is extracted from the source text.